The impact of disopyramide on exercise capacity among patients with obstructive hypertrophic cardiomyopathy: beyond left ventricular outflow tract gradient - Top-Institutions - MDSpire

The impact of disopyramide on exercise capacity among patients with obstructive hypertrophic cardiomyopathy: beyond left ventricular outflow tract gradient

  • By

  • Geza Halasz

  • Lorenzo Lupo Dei

  • Francesco Moroni

  • Michael P Ayers

  • Paolo Ciacci

  • Guido Giacalone

  • Raffaella Mistrulli

  • Marco Redivo

  • Santiago Orellana

  • Domenico Gabrielli

  • Massimo Piepoli

  • Federica Re

  • June 8, 2024

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Cardiology
    • Cardiomyopathy
    • Genetic Heart Diseases

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Cardiology
    • Heart Failure
    • Cardiomyopathy

  • #3

    Brigham and Women's Hospital
    Brigham and Women's Hospital

    Boston, MA

    Key Differentiators

    • Cardiology
    • Heart Failure
    • Genetic Cardiomyopathies

  • #4

    San Camillo Forlanini Hospital
    San Camillo Forlanini Hospital

    Rome, Italy

    Key Differentiators

    • Cardiology
    • Heart Failure
    • Cardiomyopathy

  • #5

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Genetic Heart Disease
    • Heart Failure

Original Source(s)

The impact of disopyramide on exercise capacity among patients with obstructive hypertrophic cardiomyopathy: beyond left ventricular outflow tract gradient

  • by Geza Halasz, Lorenzo Lupo Dei, Francesco Moroni, Michael P Ayers, Paolo Ciacci, Guido Giacalone, Raffaella Mistrulli, Marco Redivo, Santiago Orellana, Domenico Gabrielli, Massimo Piepoli, Federica Re

  • June 8, 2024

Related Content

Role of psychological resilience and psychological distress in linking fear of disease progression to quality of life in chronic heart failure: a cross-sectional serial mediation analysis

FDA Approves Baxdrostat for Resistant Hypertension

Phase 3 findings support the oral therapy in adults with persistent blood pressure elevation despite multidrug treatment.

Publisher Correction: Rapid prediction of cardiac activation in the left ventricle with geometric deep learning: a step towards cardiac resynchronization therapy planning